Citigroup’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-568,440
| Closed | -$48.3M | – | 7805 |
|
|
2020
Q3 | $48.3M | Buy |
568,440
+427,194
| +302% | +$21.6M | 0.03% | 467 |
|
|
2020
Q2 | $5M | Sell |
141,246
-29,779
| -17% | -$871K | ﹤0.01% | 1860 |
|
|
2020
Q1 | $2.31M | Buy |
171,025
+67,171
| +65% | +$1.13M | ﹤0.01% | 2359 |
|
|
2019
Q4 | $2.2M | Sell |
103,854
-147,924
| -59% | -$2.61M | ﹤0.01% | 2868 |
|
|
2019
Q3 | $3.34M | Sell |
251,778
-63,121
| -20% | -$928K | ﹤0.01% | 2318 |
|
|
2019
Q2 | $4.37M | Buy |
314,899
+242,059
| +332% | +$3.64M | ﹤0.01% | 2076 |
|
|
2019
Q1 | $1.4M | Sell |
72,840
-514,012
| -88% | -$8.28M | ﹤0.01% | 3037 |
|
|
2018
Q4 | $8.37M | Buy |
586,852
+413,285
| +238% | +$8.2M | 0.01% | 1392 |
|
|
2018
Q3 | $3.62M | Buy |
173,567
+39,591
| +30% | +$938K | ﹤0.01% | 2170 |
|
|
2018
Q2 | $3.17M | Sell |
133,976
-93,470
| -41% | -$1.88M | ﹤0.01% | 2263 |
|
|
2018
Q1 | $3.32M | Sell |
227,446
-262,385
| -54% | -$4.29M | ﹤0.01% | 2147 |
|
|
2017
Q4 | $7.92M | Buy |
489,831
+286,748
| +141% | +$3.38M | 0.01% | 1458 |
|
|
2017
Q3 | $2.84M | Buy |
203,083
+25,568
| +14% | +$255K | ﹤0.01% | 2293 |
|
|
2017
Q2 | $1.57M | Buy |
177,515
+162,215
| +1,060% | +$1.14M | ﹤0.01% | 2837 |
|
|
2017
Q1 | $99K | Sell |
15,300
-93,404
| -86% | -$473K | ﹤0.01% | 5227 |
|
|
2016
Q4 | $399K | Buy |
108,704
+76,963
| +242% | +$228K | ﹤0.01% | 4623 |
|
|
2016
Q3 | $103K | Buy |
31,741
+3,211
| +11% | +$8.98K | ﹤0.01% | 5190 |
|
|
2016
Q2 | $66K | Sell |
28,530
-77,307
| -73% | -$258K | ﹤0.01% | 5396 |
|
|
2016
Q1 | $265K | Buy |
105,837
+52,789
| +100% | +$119K | ﹤0.01% | 4819 |
|
|
2015
Q4 | $163K | Buy |
53,048
+41,820
| +372% | +$117K | ﹤0.01% | 4932 |
|
|
2015
Q3 | $19K | Sell |
11,228
-12,565
| -53% | -$32.1K | ﹤0.01% | 6080 |
|
|
2015
Q2 | $96K | Sell |
23,793
-4,250
| -15% | -$17.4K | ﹤0.01% | 5036 |
|
|
2015
Q1 | $108K | Sell |
28,043
-17,704
| -39% | -$77K | ﹤0.01% | 4980 |
|
|
2014
Q4 | $220K | Buy |
45,747
+16,952
| +59% | +$67K | ﹤0.01% | 4604 |
|
|
2014
Q3 | $107K | Buy |
28,795
+9,549
| +50% | +$32.3K | ﹤0.01% | 4707 |
|
|
2014
Q2 | $70K | Sell |
19,246
-31,227
| -62% | -$115K | ﹤0.01% | 4922 |
|
|
2014
Q1 | $213K | Buy |
50,473
+8,357
| +20% | +$41.4K | ﹤0.01% | 4270 |
|
|
2013
Q4 | $194K | Buy |
42,116
+11,194
| +36% | +$49.8K | ﹤0.01% | 4692 |
|
|
2013
Q3 | $191K | Buy |
30,922
+20,930
| +209% | +$120K | ﹤0.01% | 4199 |
|
|
2013
Q2 | $55K | Buy |
+9,992
| New | +$32.8K | ﹤0.01% | 5321 |
|
Citigroup's IMMU Position: Q4 2020 in Review
Citigroup sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 568,440 shares — an estimated $48.3M sold.
Citigroup first reported a position in IMMU in Q2 2013 and held it in 30 quarters. The position peaked at $48.3M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- Citigroup reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- Citigroup sold 568,440 Immunomedics Inc shares in Q4 2020, an estimated $48.3M.
- Citigroup first reported a position in Immunomedics Inc in Q2 2013 and held it in 30 quarters.
- Citigroup's Immunomedics Inc position peaked at $48.3M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on Citigroup's 13F filing for Q4 2020, filed 11 Feb 2021.